Philips Azurion PCI procedure
Philips announces European availability of innovations to advance personalized and efficient cardiac care at EuroPCR 2021
May 18, 2021 04:00 ET | Royal Philips
May 18, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the European availability of new innovations in its unique...
Philips Interventional Hemodynamic System with Patient Monitor IntelliVue X3
Philips introduces integrated Interventional Hemodynamic System with Patient Monitor IntelliVue X3 to improve workflow and patient focus during image-guided procedures at ACC.21
May 14, 2021 04:00 ET | Royal Philips
May 14, 2021 Continuous monitoring provides informed, timely clinical decision making and comprehensive, gap-free patient records in the cath lab and beyond Amsterdam, the Netherlands –...
Philips 2021 AGM - 1
Philips Annual General Meeting of Shareholders approves all proposals
May 06, 2021 10:15 ET | Royal Philips
May 6, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced that today’s Annual General Meeting of Shareholders (2021 AGM) has re-appointed Mr. Marnix van Ginneken as...
Future Health Index 2021 report
Philips’ Future Health Index 2021 report reveals transformative post-pandemic agenda of healthcare leaders worldwide
May 05, 2021 11:00 ET | Royal Philips
May 5, 2021 Largest global survey of its kind features critical insights from nearly 3,000 healthcare leaders across 14 countries on meeting the demands of today and their vision for...
philips-foundation-published- its-2020-annual-report
Philips Foundation publishes its 2020 Annual Report highlighting the deployment of health technology expertise for underserved communities
May 04, 2021 04:01 ET | Royal Philips
May 4, 2021  75 successful projects rolled out, including over 40 activities dedicated to combatting COVID-19 in 2020Over 7.5 million people in underserved communities provided with access to...
Philips_logo_logotype_emblem-700x128.png
Philips delivers Q1 sales of EUR 3.8 billion, with 9% comparable sales growth; net income amounts to EUR 40 million and Adjusted EBITA margin improves 390 basis points to 9.5%
April 26, 2021 01:00 ET | Royal Philips
April 26, 2021First-quarter highlights Following the agreement to sell the Domestic Appliances business to global investment firm Hillhouse Capital, this business is reported as a discontinued...
Philips Stellarex low-dose drug-coated balloon
Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex .035” low-dose Drug-Coated Balloon
April 20, 2021 11:25 ET | Royal Philips
April 20, 2021 Stellarex is the only Drug-Coated Balloon (DCB) to consistently demonstrate no difference in mortality every year through five years when compared with percutaneous transluminal...
Blades for OneBlade in package
Philips produces one hundred millionth blade for its OneBlade, the product that disrupted the grooming market
April 20, 2021 04:00 ET | Royal Philips
April 20, 2021 Since its launch in 2016, the Philips OneBlade has disrupted grooming markets worldwide, creating a new category - a single tool for shaving, trimming and edgingOneBlade Face + Body...
Philips Magnetic Resonance – Ingenia MR-OR - interoperative system
Philips installs leading digital imaging solutions at new Central Acute Services Building of Westmead Hospital in Sydney Australia
April 19, 2021 04:00 ET | Royal Philips
April 19, 2021 New state-of-the-art Central Acute Services Building at Westmead Hospital features next-generation diagnostic and neurovascular imaging solutions, aimed at improving the efficiency...
Lumify with Reacts in Use_ICU
Philips showcases impact of tele-ultrasound advancing Precision Diagnosis at AIUM virtual event
April 09, 2021 09:00 ET | Royal Philips
April 9, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its participation in the upcoming Annual Integrative...